What is Bioventus's other financing?

Bioventus (BVS) reported other financing of $0 in Q1 2026.

How has Bioventus's other financing changed year-over-year?

Bioventus's other financing decreased by 100.0% year-over-year, from $9M to $0.

What is the long-term trend for Bioventus's other financing?

Over 2 years (2021 to 2024), Bioventus's other financing has grown at a -100.0% compound annual growth rate (CAGR), from -$404K to $0.

What does other financing mean?

Miscellaneous financing cash flows not classified in specific line items.

Bioventus BVS Other Financing

Other Financing at other companies

Orthofix Medical Inc.OFIX

$250K—

Zimmer Biomet HoldingsZBH

$69M+297%

MedtronicMDT

$70M+567%

ArtivionAORT

-$210K-18.0%

EnovisENOV

-$1.4M+38.4%

Envista Holdings CorporationNVST

-$400K—

Other financials

Income statement

See full

Revenue$132.1M+6.6%

Gross profit$90.8M+9.3%

Operating income$8.4M+72.8%

Net income$3.1M+218%

EPS (diluted)$0.04+200%

Balance sheet

See full

Cash & equivalents$35.8M+57.2%

Total debt$288.4M-21.2%

Total equity$188.9M+27.5%

Total assets$650.5M-5.9%

Cash flow

See full

Operating cash flow$8.9M+146%

CapEx$574.0K-30.5%

Free cash flow$8.4M+141%

Valuation

See full

Market cap$659.19M+51.7%

Enterprise value$911.76M+17.2%

P/E23.1×—

P/S1.1×+0.4×

Profitability

See full

Gross margin68.7%+1.2pp

Operating margin10%—

Net margin4.9%+3.2pp

FCF margin17.5%+13.2pp

Returns & leverage

See full

Return on equity16.9%+10.9pp

Debt / equity1.5×-0.9×

Current ratio1.7×+0.3×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's other financing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bioventus's other financing?: Bioventus (BVS) reported other financing of $0 in Q1 2026.
How has Bioventus's other financing changed year-over-year?: Bioventus's other financing decreased by 100.0% year-over-year, from $9M to $0.
What is the long-term trend for Bioventus's other financing?: Over 2 years (2021 to 2024), Bioventus's other financing has grown at a -100.0% compound annual growth rate (CAGR), from -$404K to $0.
What does other financing mean?: Miscellaneous financing cash flows not classified in specific line items.